Effects of ElevATP on Body Composition and Athletic Performance
1 other identifier
interventional
51
0 countries
N/A
Brief Summary
This study will examine the effects of supplemental ElevATP with or without a blend of extended-release caffeine and B vitamins for changes in body composition, athletic performance, and hematology over a 12 week intervention period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Aug 2014
Shorter than P25 for not_applicable healthy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 22, 2016
CompletedFirst Posted
Study publicly available on registry
June 30, 2016
CompletedJune 30, 2016
June 1, 2016
4 months
June 22, 2016
June 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in Body Fat (in kilograms)
Measured by dual emissions x-ray absorptiometry (DEXA), bioelectric impedance analysis (BIA), and bioelectric impedance spectroscopy (BIS)
measure at 0, 4, 8, 10, and 12 weeks of the intervention
Change in Muscle Mass (in kilograms)
Measured by dual emissions x-ray absorptiometry (DEXA), bioelectric impedance analysis (BIA), and bioelectric impedance spectroscopy (BIS)
measure at 0, 4, 8, 10, and 12 weeks of the intervention
Change in Body Fat percent (%)
Measured by dual emissions x-ray absorptiometry (DEXA), bioelectric impedance analysis (BIA), and bioelectric impedance spectroscopy (BIS)
measure at 0, 4, 8, 10, and 12 weeks of the intervention
Change in Cross-sectional area of the rectus femoris (cm squared)
Measured by ultrasound at 75% femur length.
measure at 0, 4, 8, 10, and 12 weeks of the intervention
Change in Maximal strength (in kilograms)
Measured by 1-repetition maximum in the squat, bench press, and deadlift exercises.
measure at 0, 4, 8, 10, and 12 weeks of the intervention
Change in Power output (in watts)
Measured by linear force transducer and cycle ergometer
measure at 0, 4, 8, 10, and 12 weeks of the intervention
Change in vertical jump height (in centimeters)
Measured by vertec.
measure at 0, 4, 8, 10, and 12 weeks of the intervention
Secondary Outcomes (44)
Change in white blood cells (number of cells per unit of blood volume)
measure at 0, 8, and 12 weeks of the intervention
Change in red blood cells (number of cells per unit of blood volume)
measure at 0, 8, and 12 weeks of the intervention
Change in platelets (number of cells per unit of blood volume)
measure at 0, 8, and 12 weeks of the intervention
Change in neutrophils (number of cells per unit of blood volume)
measure at 0, 8, and 12 weeks of the intervention
Change in eosinophils (number of cells per unit of blood volume)
measure at 0, 8, and 12 weeks of the intervention
- +39 more secondary outcomes
Study Arms (3)
Placebo
PLACEBO COMPARATORParticipants will receive a flavored water placebo supplement. Part of the supplemental intervention. This, and all groups, simultaneously took part in the exercise intervention.
ElevATP
EXPERIMENTALParticipants will receive the flavored water placebo with an additional 150mg of ElevATP (blend of ancient peat and apple extracts). Part of the supplemental intervention.This, and all groups, simultaneously took part in the exercise intervention.
ElevATP w/Caffeine
EXPERIMENTALParticipants will receive the flavored water placebo with an additional 150mg of ElevATP (blend of ancient peat and apple extracts), a 180 mg blend of caffeine (caffeine anhydrous, pterostilbene-bound caffeine), and 38mg B vitamins. Part of the supplemental intervention.This, and all groups, simultaneously took part in the exercise intervention.
Interventions
participants were provided with either placebo, placebo + ElevATP, or placebo + ElevATP + Caffeine + Vitamins.
Concurrent with the supplemental intervention, all subjects participated in a resistance exercise intervention.
Eligibility Criteria
You may qualify if:
- Age between 18-35 years
- Healthy as assessed by Pre-exercise Testing Health Status and General Information Questionnaire
- Strength trained for a minimum of 3 years as assessed by pre-exercise testing questionnaire
- Minimum strength requirements of 1x bodyweight bench press and 1.5x bodyweight squat and deadlift.
- Subject has provided written and dated informed consent to participate in the study
You may not qualify if:
- Having a history of medical events that may significantly affect the study outcome, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders
- Use of medicine that may significantly affect the study outcome
- Use of any ergogenic aids for one month prior to the onset of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MusclePharm Sports Science Institutelead
- VDF FutureCeuticals Inc.collaborator
Related Publications (1)
Joy JM, Vogel RM, Moon JR, Falcone PH, Mosman MM, Pietrzkowski Z, Reyes T, Kim MP. Ancient peat and apple extracts supplementation may improve strength and power adaptations in resistance trained men. BMC Complement Altern Med. 2016 Jul 18;16:224. doi: 10.1186/s12906-016-1222-x.
PMID: 27430755DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
jordan m joy, ms
MusclePharm Sports Science Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2016
First Posted
June 30, 2016
Study Start
August 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
June 30, 2016
Record last verified: 2016-06